Physician profile
Taylor Brooks
NPI 1255838116
$1,978.47
in general payments reported to CMS, 2019-2025
8 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $229 · 2024: $1,397 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $989 · Food and Beverage: $913 · Education: $76.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $989.32 |
| Food and Beverage | $912.60 |
| Education | $76.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $1,322.93 | 2024-2025 | |
| Genmab U.S., INC. | $250.97 | 2023-2025 | Epkinly |
| Genentech USA, INC. | $145.79 | 2024-2025 | |
| Beone Medicines USA, INC. | $125.00 | 2025 | Brukinsa |
| Lilly USA, LLC | $76.55 | 2023 | |
| Biotissue Holdings INC. | $40.64 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.59 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.